Boston, MA, 02/19/2014 – Ciena Corporation (NYSE:CIEN) is basking in the positivity of its recent partnership agreement with Ericsson, the mobile infrastructure leader. On Friday, Ciena inked a deal with Ericsson to co-develop integrated Ethernet networking sulutionsalongwith carrier software-defined networking offerings. The deal has received positive response from all corners as analysts from research firms Nomura, Evercore and MKM have raised their price targets. Nomura’s analyst Stuary Jeffrey has revised the EPS for FY16 upwards from $1.92 to $2.33. He based his thoughts on the expected lift to Ciena’s market share in EMEA and Asia Pacific by 2%. Citi’s Ehud Gelblum too conveys the same thoughts as he sees the partnership to improve Ciena’s reach in the developing markets. Moreover, Gelblum also anticipates the Ciena Corporation (NYSE:CIEN)’s carrier Ethernet gear will get a boost through Ericsson.

BoehringerIngelheim, the German drugmaker said on Wednesday that the hearing on lawsuits filed against its stroker prevention drug, Pradaxa will start in August. Boehringer’sPradaxa competes with the Bristol Myers Squibb Co. (NYSE:BMY)‘s pill and is facing over 2,000 lawsuits in America with claimants alleging that the pills caused severe and fatal bleeding. Moreover, Boehringer is accused of being ignorant in labelling Pradaxa for the associated risks. While, Boehringer said that the side effects attached to the pill was known, but it were not significant in comparison to the life-saving ability of the drug.

Williams Companies, Inc. (NYSE:WMB) is scheduled to release its fourth quarter earnings after the close of the today’s trading session. As per the market consensus, the earnings per share of the company is estimated as $0.22 per share and the revenue forecasts are $1.64 billion. Ahead of the earnings, two of the hedge funds, that is, Corvex Management and Soroban Capital Partners have disclosed their stake in the company, which is up from their earlier stake of 5.3%. The two hedge funds have been following the company to review options of more mergers. They have also engaged investment adviser Moelis& Company to evaluate their options.